Natural history
BiologicalNatural history of pancreatic diseases
NCT Number: NCT07177599
Using data from the Global Burden of Disease Study 2021, the investigators analyzed age-standardized incidence, mortality, and disability-adjusted life-years (DALYs) for pancreatic cancer and pancreatitis in adults aged ≥70 years across 204 countries and territories, stratified by sex, Socio-Demographic Index (SDI), health system performance, and region. The investigators calculated estimated annual percentage changes (EAPCs), applied age-period-cohort modelling, and used Bayesian models to project future burden. Attributable burdens for key risk factors were also estimated.
Looking for future studies?
Notify Me70 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Natural history of pancreatic diseases
Time frame: 1990-2021
The number of new cases of a givencause during a given period in aspecified population. It is xpressed as the number of newcases in a year divided by the mid-year population size.
Time frame: 1990-2021
Deaths occurring in a population during a certain time period.
Time frame: 1990-2021
The sum of years lost due to premature death (YLLs) and yearslived with disability (YLDs). DALYs are also defined as years of healthy life lost.
Changhai Hospital
Other
Global, Regional, and National Burdens of Pancreatic Cancer and Pancreatitis Among Older Adults From 1990 to 2021 With Projections to 2040: A Comprehensive and Comparative Investigation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03914950
Digestive System Diseases, Digestive System Neoplasms
View Trial DetailsNCT02027311
Adenocarcinoma, Bile Duct Diseases
Jeju City, Jeju Special Self-Governing Province, South Korea
View Trial DetailsNCT00639314
Ampullary Cancer, Bile Duct Cancer
Wakayama, Japan
View Trial DetailsNCT00628186
Ampullary Cancer, Bile Duct Cancer
811-1 Kimiidera, Wakayama, Wakayama, Japan
View Trial Details